Mahivir Singh Khanna

Title: Mahivir Singh Khanna: Innovator in Pharmaceutical Chemistry

Introduction

Mahivir Singh Khanna is a notable inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of treatments for schizophrenia. His work has been recognized for its impact on the medical community and the advancement of therapeutic options.

Latest Patents

One of Mahivir Singh Khanna's key inventions is a patent titled "Process for the preparation of ziprasidone." This invention relates to processes for the preparation of substantially pure ziprasidone, including the preparation of acid addition salts of ziprasidone. More specifically, it focuses on the preparation of substantially pure hydrochloride salt of ziprasidone. The invention also encompasses pharmaceutical compositions that include the substantially pure ziprasidone or ziprasidone hydrochloride, which are used for treating schizophrenia. He holds 1 patent in this area.

Career Highlights

Mahivir Singh Khanna has had a distinguished career at Ranbaxy Laboratories, Inc., where he has contributed to various innovative projects. His expertise in pharmaceutical processes has played a crucial role in the development of new medications. His work has not only advanced the field but has also provided new hope for patients suffering from mental health disorders.

Collaborations

Throughout his career, Mahivir Singh Khanna has collaborated with several talented individuals, including Yatendra Kumar and Mohan Prasad. These collaborations have fostered a creative environment that has led to significant advancements in pharmaceutical research and development.

Conclusion

Mahivir Singh Khanna's contributions to pharmaceutical chemistry, particularly through his patent on ziprasidone, highlight his role as an innovator in the field. His work continues to influence the development of effective treatments for schizophrenia, showcasing the importance of innovation in healthcare.